Emerging drug targets for achondroplasia

被引：2
|
作者：
Savarirayan, Ravi [1 ]
机构：
[1] Univ Melbourne, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia
来源：
EXPERT OPINION ON THERAPEUTIC TARGETS | 2022年 / 26卷 / 05期
关键词：
Skeletal dysplasia; therapeutics; clinical trials; achondroplasia; drug targets; FGFR3; mutation; fibroblast growth factor receptor 3; mouse models; GROWTH; MUTATIONS; DWARFISM; CHILDREN; THERAPY; CNP;
D O I：
10.1080/14728222.2022.2077722
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：389 / 391
页数：3
相关论文
共 50 条
  • [31] Biomarkers and Emerging Drug Targets in Neuropsychiatry (Part II)
    Marazziti, Donatella
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (36) : 5691 - 5691
  • [32] Muscle wasting: emerging pathways and potential drug targets
    Domaniku, Aylin
    Bilgic, Sevval Nur
    Kir, Serkan
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2023, 44 (10) : 705 - 718
  • [33] GPCRs: Emerging anti-cancer drug targets
    Gutierrez, Ainhoa Nieto
    McDonald, Patricia H.
    CELLULAR SIGNALLING, 2017, 41 : 65 - 74
  • [34] Emerging Targets in Kidney Cancer: Opportunities for Drug Development
    Stadler, Walter
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (05) : 299 - 300
  • [35] Future perspectives of emerging novel drug targets and immunotherapies to control drug addiction
    Malik, Jonaid Ahmad
    Agrewala, Javed N.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 119
  • [36] Chemical Genomics and Emerging DNA Technologies in the Identification of Drug Mechanisms and Drug Targets
    Olsen, Louise Cathrine Braun
    Faergeman, Nils Joakim
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2012, 12 (12) : 1331 - 1345
  • [37] Emerging therapies for Achondroplasia: changing the rules of the game
    Kumble, Smitha
    Savarirayan, Ravi
    EXPERT OPINION ON EMERGING DRUGS, 2021, 26 (04) : 425 - 431
  • [38] Current and emerging avenues for Alzheimer's disease drug targets
    Loera-Valencia, R.
    Cedazo-Minguez, A.
    Kenigsberg, P. A.
    Page, G.
    Duarte, A., I
    Giusti, P.
    Zusso, M.
    Robert, P.
    Frisoni, G. B.
    Cattaneo, A.
    Zille, M.
    Boltze, J.
    Cartier, N.
    Buee, L.
    Johansson, G.
    Winblad, B.
    JOURNAL OF INTERNAL MEDICINE, 2019, 286 (04) : 398 - 437
  • [39] Gastroparesis syndromes: emerging drug targets and potential therapeutic opportunities
    Naing, Le Yu
    Heckroth, Matthew
    Mathur, Prateek
    Abell, Thomas L.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, : 245 - 262
  • [40] Lipid metabolic enzymes: emerging drug targets for the treatment of obesity
    Yuguang Shi
    Paul Burn
    Nature Reviews Drug Discovery, 2004, 3 : 695 - 710
12345